News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
The Institute of Cancer and Crisis – Dr. Arakelyan Delivered an Impactful Speech at the ASCO 2025 Global Cancer Care Delivery Session
Jemma Arakelyan/LinkedIn
Jun 4, 2025, 02:27

The Institute of Cancer and Crisis – Dr. Arakelyan Delivered an Impactful Speech at the ASCO 2025 Global Cancer Care Delivery Session

The Institute of Cancer and Crisis (ICC) posted on LinkedIn:

“We are proud to share that Dr. Arakelyan delivered an impactful speech at the ASCO 2025 Global Cancer Care Delivery session. She addressed the often-overlooked effects of conflict on cancer care, emphasizing the urgent need for innovation and support in affected regions.
Her insights, alongside those of other expert leaders Miriam Mutebi, Fidel Rubagumya , Manoj Menon, Ruffo Freitas-Junior, Ru’a Rimawi underscore our collective responsibility to enhance cancer care globally.”

The Institute of Cancer and Crisis - Dr. Arakelyan Delivered an Impactful Speech at the ASCO 2025 Global Cancer Care Delivery Session

More posts featuring Jemma Arakelyan.

ASCO 2025 ASCO 2025 Global Cancer Care Delivery session cancer Fidel Rubagumya Jemma Arakelyan Manoj Menon Miriam Mutebi OncoDaily Oncology Ruffo Freitas-Junior The Institute of Cancer and Crisis
Special Coverage
Positive
Sep 8, 2025, 14:50
Rasha Aboelhassan: Thoracic Cancer Care and Investigation at WCLC 2025
Science
Sep 8, 2025, 14:18
Douglas Flora: Bridging the Mental Health Gap in Cancer Care with AI
OncoDaily Pulse
Sep 8, 2025, 13:40
Armine Badeyan: Meet the Experts of VIRO 2025
OncoDaily Pulse
Sep 8, 2025, 13:39
Gang Zhu: Meet the Experts of VIRO 2025
Career Updates
Sep 8, 2025, 13:32
Nazima Hodjaeva: Internship in Endoscopic Gynecology at a Leading French Center
Science
Sep 8, 2025, 13:16
B.S. Bhati: Cracking the Brain Barrier - Lazertinib vs Osimertinib in EGFR+ NSCLC
Science
Sep 8, 2025, 12:53
Myeloma Paper of the Day, September 8th, Suggested by Robert Orlowski
Trial Updates
Sep 8, 2025, 12:36
Top Colorectal Cancer Trials to Watch at ESMO 2025
Science
Sep 8, 2025, 12:11
Amol Akhade: EGFRm NSCLC at WCLC25 - Two Curves, Two Stories
Voices
Sep 8, 2025, 12:04
Sendurai Mani: Looking Forward to My Presentation at the MD Anderson Cancer Center Breast Medical Oncology Team
Voices
Sep 8, 2025, 11:56
Belgian Society of Medical Oncology Webinar: Exploring Radioligand Therapy in Oncology
Insight
Sep 8, 2025, 11:43
Evandro de Azambuja: Managing Relapses During or After Adjuvant CDK4/6 Inhibitors in HR+/HER2− Early Breast Cancer